Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.


Founders Noubar Afeyan



Unlock datapoints

Portfolio analytics


News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 6
Average round size
The average size of a deal this fund participated in
Portfolio companies 2
Rounds per year 0.17
Lead investments 1
Follow on index
How often the fund supports its portfolio startups at next rounds
Exits 1
Key employees Soon

Areas of investment

  • Pharmaceutical
  • Biotechnology
  • Therapeutics
  • Health Care

Cephalon appeared to be the Corporate Investor, which was created in 1987. The venture was found in North America in United States. The main office of represented Corporate Investor is situated in the Malvern.

The fund is constantly included in less than 2 investment rounds annually. The increased amount of exits for fund were in 2011. Deals in the range of 10 - 50 millions dollars are the general things for fund. The top activity for fund was in 2011.

The usual cause for the fund is to invest in rounds with 2 partakers. The meaningful sponsors for the fund in investment in the same round are Novo Nordisk, MacAndrews & Forbes, Incorporated. In the next rounds fund is usually obtained by Whiz Partners, National Institutes of Health, Forest Laboratories.

The current fund was established by Noubar Afeyan.

For fund there is no match between the location of its establishment and the land of its numerous investments - Japan. Among the most popular portfolio startups of the fund, we may highlight SymBio Pharmaceuticals, TransTech Pharma. Among the most successful fund investment fields, there are Health Care, Pharmaceutical. The fund has specific favorite in a number of founders of portfolio startups. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund.

Read more

Look at other 50 related and similar funds Collapse list
Fund NameLocation
First Star Ventures Boston, Massachusetts, United States
FoodFutureCo New York, New York, United States
Konvoy Ventures Colorado, Denver, United States
KuE Capital Ciudad Valles, Mexico, San Luis Potosi
m2f investment Germany, North Rhine-Westphalia, Recklinghausen
Mohawk Ventures -
NCPDP Arizona, Scottsdale, United States
Onevest New York, New York, United States
Technology & Innovation Fund New Jersey, Toms River, United States
Zhengyou Asset China, Ningbo Shi, Zhejiang


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Cephalon?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 6
Average round size 115M
Rounds per year 0.17
Peak activity year 2009
Lead investments 1
Follow on index 0.67
Exits 1
Group Appearance index 0.83
Crunchbase icon

Content report

The following text will be sent to our editors: